Pacific Biosciences of California Inc (NASDAQ:PACB) currently has a daily average trading volume of 11.30M but it saw 28516659 shares traded in last market. With a market cap of 431.88M USD, the company’s current market price of $1.45 came rising about 20.83 while comparing to the previous closing price of $1.20. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.70 and as low as $1.08. In the recent trading on the day, stock has struck highest price mark of $1.28 while lowest mark touched by it was $1.49.
Taking a look at 20-day trading activity of Pacific Biosciences of California Inc (PACB) gives us an average price of $1.2475, while its current price level is -60.81% below from 52-week high level whereas it is 34.26% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.3973 while that of 200 days or SMA-200 reads an average of $1.6889. A closer look into the stock’s movement over the week reveals that its volatility is standing at 14.08% during that period while stretching the period over a month that decreases to 9.33%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 57.06 which implies that the stock is in neutral territory.
Over the week, PACB’s stock price is moving 14.17% up while it is 10.69% when we observe its performance for the past one month. Year-to-date it is -20.77% down and over the past year, the stock is showing a downside performance of -57.97%.
The company is expected to be releasing its next quarterly report on 2025-Feb-12, for which analysts forecasted an EPS of -0.19 while estimate for next year EPS is -0.73. In next quarter, company is expected to be making quarterly sales of $39.7M as analysts are expecting the sales for current fiscal year at $160.85M and seeing the company making $199.01M in sales next year. Moreover, analysts are in estimates of $36.9M for current-quarter revenue.
Currently, Pacific Biosciences of California Inc’s total number of outstanding shares is 294.42M with 8.84% of that held by the insiders while 78.11% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -26.40% and return on equity (ROE) at -51.11%. Stock’s beta reads 1.95. Stock has a price to book (P/B) ratio of 0.84 while price to sale or P/S ratio amounts to 2.80. Its return on asset (ROA) is -20.53% on average.
